Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Benjamin Moritz
Observed name:
Moritz, Benjamin
Institution:
Charles River Laboratories (United States)
Observed institutions:
Center for Integrated Protein Science Munich,
Roche Pharma AG (Germany),
Charles River Laboratories (United States),
Ludwig-Maximilians-Universität München
OpenAlex ID:
A5048508315
CMV promoter mutants with a reduced propensity to productivity loss in CHO cells
2015
·
Benjamin Moritz
, Peter B. Becker
, et al.
·
Scientific Reports
·
101
PDF
Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development
2024
·
Amanda Hays
, Mark Wissel
, et al.
·
The AAPS Journal
·
59
PDF
High levels of histone H 3 acetylation at the CMV promoter are predictive of stable expression in Chinese hamster ovary cells
2016
·
Benjamin Moritz
, Laura Woltering
, et al.
·
Biotechnology Progress
·
40
Development of a 10 g/L process for a difficult-to-express multispecific antibody format using a holistic process development approach
2024
·
Mégane Peltret
, Patrick Vetsch
, et al.
·
Journal of Biotechnology
·
8
Technical Considerations of Pharmacokinetic Assays for LNP-mRNA Drug Products by RT-qPCR
2025
·
Jason Pennucci
, Amanda Hays
, et al.
·
The AAPS Journal
·
7
PDF
Prevention and prediction of production instability of CHO-K1 cell lines by the examination of epigenetic mechanisms
2015
·
Moritz, Benjamin
Show more works
View as search
Works count:
6
Citation count:
215
H-index:
5
I10-index:
3
Year
Topic
Type